Get ready for another earnings season highlight! Procter & Gamble (PG), a household name synonymous with everyday essentials, will unveil its first-quarter financial performance on Friday, October 18th, before the market opens. Wall Street analysts are anticipating a solid quarter, with a projected earnings per share (EPS) of $1.90, a healthy bump from the $1.83 reported in the same period last year. Additionally, revenue for the recent quarter is expected to reach $21.91 billion, a significant increase from the $19.78 billion recorded in the year-ago period. These figures are based on data from Benzinga Pro, a leading financial data platform.
While Procter & Gamble delivered a solid fourth quarter in FY24, with sales reaching $20.53 billion, it fell slightly short of analyst expectations of $20.74 billion. This modest miss led to a 0.1% dip in the company’s share price, closing at $172.28 on Thursday.
So, what do analysts think about Procter & Gamble’s upcoming earnings report and its potential impact on the stock price? Let’s dive into the latest insights from some of Benzinga’s most accurate analysts:
*
DA Davidson’s Linda Bolton Weiser
maintained a Neutral rating for PG, with a price target of $159. This analyst boasts an accuracy rate of 61%, suggesting a balanced perspective on the company’s prospects.*
Barclays’ Lauren Lieberman
took a more cautious approach, downgrading the stock from Overweight to Equal-Weight, with a price target of $163. This analyst has an accuracy rate of 63% and may be anticipating potential challenges for the company in the near term.*
JP Morgan’s Andrea Teixeira
remains optimistic about PG’s future, maintaining an Overweight rating and boosting the price target from $179 to $186. With a 61% accuracy rate, this analyst sees significant growth potential for the company.*
TD Cowen’s Robert Moskow
initiated coverage of PG with a Buy rating and a price target of $189, demonstrating strong confidence in the company’s future. This analyst has an accuracy rate of 65%, indicating a high level of predictive success.*
Stifel’s Mark Astrachan
held a more conservative view, maintaining a Hold rating, but raising the price target from $157 to $161. This analyst has an impressive accuracy rate of 78%, suggesting a cautious yet optimistic approach.The diverse range of analyst opinions highlights the complexity of evaluating Procter & Gamble’s future prospects. While some analysts are bullish on the company’s growth potential, others are more cautious, considering factors such as market competition and global economic uncertainties. The upcoming earnings release will provide crucial insights into Procter & Gamble’s performance and its trajectory moving forward.
Stay tuned for the earnings announcement on Friday, October 18th, and see how the market reacts to Procter & Gamble’s latest financial results.
